Found 27 matching trials
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease PHASE1 This study is being conducted to determine the safety, tolerability, and ph...
Show More Location
Pacific Research Network, Inc.
Learn More & Join Trial
Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease PHASE4 This study used two doses of rivastigmine transdermal patch (5 cm\^2, 10 cm...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Masitinib in Patients With Mild to Moderate Alzheimer's Disease PHASE3 The purpose of this study is to assess the safety and efficacy of masitinib...
Show More Location
MHAT Sveta Marina
Learn More & Join Trial
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia PHASE4 This phase IIIb study is intended to implement a consistent treatment way f...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h) PHASE1 The present clinical trial will be conducted in order to compare the bioava...
Show More Location
SocraTec R&D GmbH, Clinical Pharmacology Unit
Learn More & Join Trial
Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients PHASE3 The purpose of this pilot-trial is the feasibility of a large randomized, p...
Show More Location
University Medical Center
Learn More & Join Trial
Rivastigmine in Mild Alzheimer's Disease, FMRI Study NA The purpose of the study is to investigate the effect of rivastigmine given...
Show More Location
Kuopio University Hospital
Learn More & Join Trial
Toward a Computationally-Informed, Personalized Treatment for Hallucinations EARLY_PHASE1 Auditory hallucinations are among the most distressing aspects of psychotic...
Show More Location
Connecticut Mental Health Center
Learn More & Join Trial
Masitinib in Patients With Mild Alzheimer's Disease PHASE3 Masitinib is an orally administered tyrosine kinase inhibitor that targets ...
Show More Location
Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universitaires Pitié-Salpêtrière
Learn More & Join Trial
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence PHASE1 The purpose of this study is to determine the safety and effects of rivasti...
Show More Location
Michael E. DeBakey Veterans Affairs Medical Center
Learn More & Join Trial